Defunct Company
Total Trials
119
As Lead Sponsor
0
As Collaborator
Total Enrollment
12,788
NCT01289886
Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
Phase: Phase 1
Role: Collaborator
Start: Sep 30, 2003
Completion: Dec 31, 2003
NCT01289899
Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects
Start: Jan 31, 2004
Completion: Feb 29, 2004
NCT00209547
Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization
Phase: Phase 3
Start: Feb 29, 2004
Completion: Mar 31, 2005
NCT00209586
A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy
Start: Sep 30, 2004
NCT00209560
A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures
Start: Oct 31, 2004
NCT00209599
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy
Phase: Phase 2
Start: Feb 28, 2005
NCT00209417
Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography
Phase: Phase 4
Start: Jun 30, 2005
Completion: Jul 31, 2011
NCT00637403
Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension
Start: May 31, 2006
Completion: May 31, 2006
NCT00409539
SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)
Start: Dec 31, 2006
Completion: Jul 31, 2008
NCT02061917
Switching From Usual Brand Cigarettes to a Tobacco-heating Cigarette or Snus
Phase: N/A
Start: Feb 28, 2007
Completion: Nov 30, 2009
NCT00607386
Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy
Start: Dec 31, 2007
Completion: Jul 8, 2011
NCT01306422
Safety, Tolerability, Kinetics and Efficacy Study of Hoodia Gordonii Purified Extract (PYM50717)
Start: Mar 31, 2008
Completion: Oct 31, 2008
NCT00757237
Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa
Start: Aug 31, 2008
Completion: Nov 30, 2010
NCT02574260
An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)
Completion: Jan 31, 2010
NCT00766181
Satisfaction With Pediatric Intravenous Catheter Placement in the Emergency Department
Start: Oct 31, 2008
Completion: Apr 30, 2009
NCT00768209
A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment
Completion: Jul 31, 2009
NCT00769041
A Thorough EKG Safety Study of TA-1790 (Avanafil)
Completion: Jan 31, 2009
NCT00731549
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Start: Dec 31, 2008
Completion: Nov 30, 2013
NCT00793234
Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery
Completion: Mar 31, 2010
NCT00868361
A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel
Start: May 31, 2009
Completion: Sep 30, 2009
NCT01969994
Absorption, Metabolism, and Excretion of (-)-[2-14C]Epicatechin in Humans
Start: Dec 31, 2009
Completion: Dec 31, 2009
NCT01165554
Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels
Start: May 31, 2010
Completion: Nov 30, 2011
NCT02121873
The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage
Start: Jul 31, 2011
Completion: Aug 31, 2012
NCT01744704
Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers
Start: Jul 31, 2012
Completion: Mar 31, 2013
NCT01712828
Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
Start: Oct 1, 2012
Completion: Jan 1, 2013
NCT01717287
A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)
Start: Nov 16, 2012
Completion: Dec 11, 2013
NCT01838499
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Start: May 31, 2013
Completion: Oct 31, 2014
NCT01677338
Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects
Start: Jul 31, 2013
Completion: Jul 31, 2014
NCT02090855
Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem
Start: Sep 30, 2013
Completion: Feb 28, 2014
NCT02087917
A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia
Start: Mar 31, 2014
Completion: Dec 31, 2014
NCT01992952
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
Phase: Phase 1/2
Start: May 31, 2014
Completion: Dec 31, 2023
NCT02185898
Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes
Completion: Feb 28, 2015
NCT02248961
Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension
Completion: Aug 31, 2015
NCT02037555
Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass
Start: Jun 26, 2014
Completion: Jan 25, 2018
NCT02190708
Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole
Start: Jun 30, 2014
Completion: Aug 31, 2014
NCT02807051
To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy Subjects
Start: Sep 30, 2014
NCT02807207
To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects
Start: Oct 31, 2014
NCT02379910
A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis
Start: Nov 30, 2014
Completion: Jun 30, 2015
NCT02337543
NEO6860, a TRPV1 Antagonist, First in Human Study
Start: Jan 31, 2015
Completion: Jul 31, 2015
NCT02692040
Study of the Gut Hormone Analogue G3215 in Adult Subjects
Completion: Jan 31, 2019
NCT02807116
Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects
NCT02808455
Study to Assess the Relative Bioavailability of Pacritinib Following Oral Administration as Capsule and Solution Formulations in Healthy Subjects
Completion: Mar 31, 2015
NCT02442414
A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors
Start: Apr 7, 2015
Completion: Nov 26, 2019
NCT03655522
NAVX-010-Phase I Tolerability and Pharmacokinetic Study in Healthy Male Subjects
Start: May 14, 2015
Completion: Sep 2, 2015
NCT02502903
Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Start: Jul 13, 2015
Completion: Mar 31, 2021
NCT02480946
Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Start: Jul 31, 2015
Completion: Mar 31, 2017
NCT02823171
To Assess the Bioequivalence of Two Pacritinib Drug Product Formulations and FMI Formulation Following Oral Administration in Healthy Subjects
Start: Aug 31, 2015
Completion: Sep 30, 2015
NCT02587260
Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)
Start: Dec 17, 2015
Completion: Feb 10, 2017
NCT02680782
A Study Comparing Once-Daily vs. Twice-Daily Dosing of X4P-001 in Healthy Volunteers
Start: Jan 12, 2016
Completion: Feb 28, 2016
NCT02690142
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035
Start: Feb 29, 2016
Completion: Jan 10, 2018
NCT02725593
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Start: Jun 22, 2016
Completion: Apr 6, 2020
NCT02865915
MLE4901 vs. Placebo for the Treatment of PCOS
Start: Jul 31, 2016
Completion: Sep 30, 2017
NCT02966652
Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism
Start: Nov 3, 2016
Completion: Oct 4, 2018
NCT03004768
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants
Start: Jan 26, 2017
Completion: Feb 27, 2017
NCT03046589
DP13 SAD & MAD in Healthy Male Subjects
Start: Mar 6, 2017
Completion: Mar 27, 2018
NCT03673111
Study of the Gut Hormone Analogue Y14 in Adult Subjects
Start: Apr 10, 2017
Completion: Feb 13, 2019
NCT03179891
Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy
Start: May 25, 2017
Completion: Dec 21, 2018
NCT03159442
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects
Start: Jun 19, 2017
Completion: Oct 13, 2017
NCT03222349
Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy
Start: Aug 31, 2017
Completion: Mar 11, 2020
NCT03294356
CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes
Start: Sep 13, 2017
Completion: Nov 2, 2017
NCT03141073
Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects
Start: Oct 15, 2017
Completion: Feb 28, 2021
NCT03272165
Single Ascending Dose Study of MEDI1341 in Healthy Volunteers
Start: Oct 17, 2017
NCT03310632
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Start: Dec 1, 2017
Completion: Dec 31, 2024
NCT03340597
Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects
Start: Dec 12, 2017
Completion: Apr 13, 2018
NCT03428360
Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy
Start: Jan 23, 2018
Completion: Jun 25, 2020
NCT03402841
Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients
Start: Jan 30, 2018
Completion: Mar 10, 2022
NCT03457753
Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis
Start: Mar 1, 2018
NCT04067492
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
Start: Mar 26, 2018
Completion: May 12, 2020
NCT03679975
Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS)
Start: Apr 4, 2018
NCT03489005
Effect of BIA 5 1058 on Cardiac Repolarization
Start: Apr 9, 2018
Completion: Oct 5, 2018
NCT03502902
The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
Start: Apr 26, 2018
Completion: Mar 15, 2019
NCT03550508
Safety, Tolerability and PK/PD of JMT103 in Patients With Bone Metastases From Tumors
Start: May 21, 2018
Completion: Dec 1, 2019
NCT03102606
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
Start: May 29, 2018
Completion: Feb 8, 2021
NCT03604419
Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes
Start: Jun 13, 2018
Completion: Jul 23, 2019
NCT03804476
Phase 1 Study to Assess AER-271
Start: Jun 26, 2018
Completion: Aug 28, 2019
NCT03785054
Phase 1, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of mGlu5 NAM HTL0014242
Start: Nov 14, 2018
Completion: Mar 11, 2021
NCT03783897
A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects
Start: Nov 27, 2018
Completion: Jun 18, 2019
NCT03714815
A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Start: Dec 7, 2018
Completion: Oct 12, 2021
NCT03797391
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Start: Dec 13, 2018
Completion: Jan 15, 2026
NCT03775421
An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.
Start: Apr 11, 2019
Completion: Jan 18, 2022
NCT04008186
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
Start: Jun 14, 2019
NCT03847389
Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis
Start: Sep 9, 2019
Completion: Jul 28, 2020
NCT04305405
PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma
Start: Nov 21, 2019
Completion: Sep 12, 2022
NCT04207957
A Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim
Start: Dec 5, 2019
Completion: Sep 15, 2020
NCT04213807
A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation
Start: Dec 11, 2019
Completion: Mar 8, 2021
NCT04505397
Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study of SKL24741 in Healthy Subjects
Start: Feb 13, 2020
Completion: Oct 27, 2022
NCT04494893
ImmuneRACE - Immune Response Action to COVID-19 Events
Start: Apr 24, 2020
Completion: Apr 23, 2021
NCT04452474
Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).
Phase: Phase 2/3
Start: Jun 30, 2020
Completion: Jan 29, 2021
NCT04116658
First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma
Start: Jul 13, 2020
Completion: Mar 4, 2024
NCT05021666
A Phase 1, Double-blind, Randomized, Placebo-controlled, Single- and Multiple-dose Escalating Study
Start: Jul 29, 2020
Completion: Aug 12, 2022
NCT04532957
A Multiple Ascending Dose Study to Investigate Safety of KBP-7072 in Healthy Subjects
Start: Aug 11, 2020
Completion: Oct 15, 2020
NCT04534699
Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment
Start: Aug 27, 2020
Completion: Nov 19, 2020
NCT04412616
ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies
Start: Sep 1, 2020
Completion: Jul 6, 2026
NCT04540393
AZD1222 Vaccine for the Prevention of COVID-19
Start: Sep 2, 2020
Completion: May 11, 2022
NCT04557397
Fruquintinib CYP3A Inhibitor and Inducer Study
Completion: Oct 18, 2020
NCT04620161
A Proof of Concept Study of Pradigastat in Patients With Functional Constipation
Start: Sep 22, 2020
Completion: Jun 3, 2022
NCT04625855
Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects
Start: Sep 30, 2020
Completion: Oct 16, 2020
NCT04583982
ImmuneSense™ COVID-19 Study
Start: Oct 9, 2020
Completion: Dec 4, 2020
NCT04606537
Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects
Start: Oct 24, 2020
Completion: Nov 30, 2020
NCT04672083
A Clinical Study of the HIV Drug CPT31 in Healthy Volunteers
Start: Nov 16, 2020
Completion: Apr 29, 2021
NCT04634812
Mass Balance Study of KBP-5074 in Healthy Male Subjects
Start: Dec 3, 2020
Completion: Dec 23, 2020
NCT04691115
Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects
Start: Dec 16, 2020
Completion: Dec 8, 2021
NCT04676867
Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19
Start: Jan 11, 2021
Completion: May 17, 2021
NCT04768868
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors
Start: Feb 25, 2021
Completion: Aug 30, 2023
NCT04607655
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
Start: Mar 31, 2021
Completion: Jul 31, 2022
NCT05664672
Study to Evaluate Changes in Smokers Using on!® Nicotine Pouches
Start: May 11, 2021
Completion: Aug 31, 2021
NCT04881955
Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects
Start: May 12, 2021
Completion: Sep 7, 2021
NCT04604782
A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Start: May 20, 2021
Completion: Dec 31, 2026
NCT04478825
Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Start: Jun 1, 2021
Completion: Aug 24, 2021
NCT04834778
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Start: Jun 8, 2021
Completion: Jan 30, 2024
NCT04596293
Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Start: Jun 11, 2021
Completion: Jul 12, 2022
NCT04662528
Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL
Start: Jun 30, 2021
Completion: Oct 31, 2022
NCT04801095
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Start: Jul 14, 2021
Completion: Aug 8, 2025
NCT05006118
Pharmacokinetics and Excretion of Oral [14C]-Rodatristat Ethyl
Start: Sep 23, 2021
Completion: Oct 6, 2021
NCT04880109
A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.
Start: Oct 20, 2021
Completion: Apr 28, 2022
NCT05082779
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159
Start: Oct 26, 2021
Completion: Oct 12, 2022
NCT05084560
Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug
Start: Dec 10, 2021
Completion: May 22, 2023
NCT05121948
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)
Start: Feb 23, 2022
Completion: Mar 1, 2024